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Abstract
Intestinal fibrosis (IF) is a major complication of inflammatory bowel disease.
IF research is limited by the lack of relevant in vitro and in vivo models. We
evaluated precision-cut intestinal slices (PCIS) prepared from human, rat, and
mouse intestine as ex vivo models mimicking the early-onset of (human) IF.
Precision-cut intestinal slices prepared from human (h), rat (r), and mouse
(m) jejunum, were incubated up to 72 h, the viability of PCIS was assessed by
ATP content and morphology, and the gene expression of several fibrosis
markers was determined. The viability of rPCIS decreased after 24 h of incu-
bation, whereas mPCIS and hPCIS were viable up to 72 h of culturing. Fur-
thermore, during this period, gene expression of heat shock protein 47 and
plasminogen activator inhibitor 1 increased in all PCIS in addition to aug-
mented expression of synaptophysin in hPCIS, fibronectin (Fn2) and TGF-b1
in rPCIS, and Fn2 and connective tissue growth factor (Ctgf) in mPCIS. Addi-
tion of TGF-b1 to rPCIS or mPCIS induced the gene expression of the fibro-
sis markers Pro-collagen1a1, Fn2, and Ctgf in both species. However, none of
the fibrosis markers was further elevated in hPCIS. We successfully developed
a novel ex vivo model that can mimic the early-onset of fibrosis in the intes-
tine using human, rat, and mouse PCIS. Furthermore, in rat and mouse PCIS,
TGF-b1 was able to even further increase the gene expression of fibrosis
markers. This indicates that PCIS can be used as a model for the early-onset
of IF.
Introduction
Intestinal fibrosis (IF) is a major complication that can
occur in inflammatory bowel disease (IBD), after radia-
tion therapy or transplantation. IF is a result of chronic
inflammation or injury and originates from inflammatory
and immune processes acting simultaneously on many
different cell types (Rieder and Fiocchi 2009). The imbal-
ance between inflammation/injury and tissue repair leads
to excessive accumulation of collagen, fibronectin, and
other extracellular matrix (ECM) proteins (Rieder et al.
2007). Due to the luminal structure of the intestine,
thickening of its wall by fibrosis causes stenosis, eventu-
ally requiring surgical intervention (Froehlich et al. 2005).
In Crohn’s Disease (CD), progressive IF leads to symp-
tomatic bowel strictures and stenosis due to narrowing of
the lumen in 30% of patients (Silverstein et al. 1999).
Despite major pharmacological advances in the inflamma-
tory component of the disease, the incidence of stricture
formation in CD has not markedly changed in the past
10 years (Latella et al. 2013). CD patients that barely suf-
fer from inflammation can still have extensive degrees of
fibrosis and stenosis and vice versa (Louis et al. 2001).
These findings suggest that distinct mechanisms of
inflammation and restitution/fibrosis exist. Up to now,
the mechanism underlying IF is still not fully understood
and there is no pharmacological therapy to prevent and/
or cure the fibrotic state.
Lack of knowledge about the mechanism of IF is a
considerable limitation in developing antifibrotic drugs
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because suitable drug targets need to be unraveled. Fur-
thermore, the currently used (human) in vitro and animal
in vivo models, mainly rodent, are not representative for
the (patho)physiology of IF in human (Fiocchi and Lund
2011). The in vivo animal models provoke substantial dis-
comfort to the animals and require large numbers of ani-
mal experiments (Rieder et al. 2012). In addition,
available in vitro and cell-culture models cannot imitate
the physiologic milieu, especially not cell–cell and cell–
extracellular matrix interactions between fibroblasts,
stellate cells, bone-marrow-derived cells, fibrocytes, and
pericytes (Rieder and Fiocchi 2008). One of the most
important profibrotic cytokines in IF is transforming
growth factor-b1 (TGF-b1) (Lund and Rigby 2008).
Through the phosphorylation of Smad proteins, TGF-b1
can activate the downstream signaling including the
expression of plasminogen activator inhibitor 1 (PAI-1)
(Kutz et al. 2001). Many of its downstream effects leading
to deposition of extracellular matrix (ECM), are mediated
by connective tissue growth factor (CTGF) (Dendooven
et al. 2011; Latella et al. 2013). Phenotypically altered res-
ident fibroblasts can turn into myofibroblasts that start to
express alpha-smooth muscle actin (aSMA) and to
produce excessive amounts of ECM. This ECM mainly
consists of collagen, fibronectin (FN2), and elastin (ELA)
(To and Midwood 2011). The maturation of collagen is
facilitated by heat shock protein 47 (HSP47) for which
collagen is the only substrate (Taguchi and Razzaque
2007). Furthermore, stellate cells which have been con-
firmed to play a role in liver fibrosis (Synaptophysin
(SYN) is a marker), are proposed to play a role in intesti-
nal fibrosis (Cassiman et al. 1999; Van de Bovenkamp
et al. 2006; Fiocchi and Lund 2011). To be able to study
the complex interplay between various intestinal cell
types, an ex vivo (human) system which can mimic the
multicellular process, namely precision-cut intestinal slices
(PCIS), was used (De Graaf et al. 2010). PCIS have been
used as a model to study drug metabolism (Van de Kerk-
hof et al. 2008), xenobiotic interactions, and drug trans-
port (Vickers and Fisher 2005; Possidente et al. 2011; Niu
et al. 2013). Furthermore, precision-cut tissue slices from
various organs have been successfully used as a model to
study fibrosis and the efficacy of antifibrotic compounds
(Westra et al. 2013). In PCIS, all intestinal cell types are
kept in their original tissue-matrix environment and
structure. Thus, cell–cell and cell-ECM interactions are
retained. Furthermore, the villus and microvillus organi-
zation is preserved, which is essential for the migration
and transformation of intestinal cells (de Graaf et al.
2007; Niu et al. 2013; Westra et al. 2013).
The aim of this study was to evaluate PCIS prepared
from human, rat, and mouse, as a novel model to mimic
the early-onset of (human) IF. This model could be used
to unravel the mechanism of intestinal fibrosis as well as
to test the efficacy of antifibrotic compounds ex vivo.
First, the viability and morphology of PCIS were studied
during culture. Second, the gene expressions of above
mentioned fibrosis markers (CTGF, aSMA, Pro-collagen
1a1 (COL1A1), FN2, HSP47, ELA, PAI-1, TGF-b1, and
SYN) were determined in PCIS in the presence and
absence of the fibrogenic factor TGF-b1.
Material and Methods
Preparation of rat and mouse intestinal
cores
Adult nonfasted male Wistar rats and C57BL/6 mice were
used (Harlan PBC, Zeist, The Netherlands). The rats and
mice were housed on a 12 h light/dark cycle in a temper-
ature and humidity controlled room with food (Harlan
chow no 2018, Horst, The Netherlands) and water ad libi-
tum. The animals were allowed to acclimatize for at least
seven days before the start of the experiment. The experi-
ments were approved by the Animal Ethical Committee
of the University of Groningen.
Rats and mice were anesthetized with isoflurane/O2
(Nicholas Piramal, London, UK). Rat jejunum (about
25 cm distal from the stomach and 15 cm in length) and
mouse jejunum (about 15 cm distal from the stomach and
10 cm in length) were excised and preserved in ice-cold
Krebs-Henseleit buffer (KHB) supplemented with 25 mM
D-glucose (Merck, Darmstadt, Germany), 25 mM NaHCO3
(Merck), 10 mM HEPES (MP Biomedicals, Aurora, OH),
saturated with carbogen (95% O2/5% CO2) and adjusted
to pH 7.4. The jejunum was cleaned by flushing KHB
through the lumen and subsequently divided into 2 cm
segments. These segments were filled with 3% (w/v) aga-
rose solution in 0.9% NaCl at 37°C and embedded in an
agarose core-embedding unit (De Graaf et al. 2010).
Preparation of human intestinal cores
Healthy human jejunum tissue was obtained for research
from intestine that was resected from patients who under-
went a pancreaticoduodenectomy (Table 1). The experi-
mental protocols were approved by the Medical Ethical
Committee of the University Medical Center Groningen.
The healthy jejunum was preserved in ice-cold KHB
until the embedding procedure (De Graaf et al. 2010; Ros-
kott et al. 2010). The submucosa, muscularis, and serosa
were carefully removed from the mucosa within an hour
after collection of the tissue. The mucosa was divided into
0.4 cm 9 1 cm sheets. These sheets were embedded in 3%
agarose (w/v) solution in 0.9% NaCl at 37°C and inserted
in embedding unit (De Graaf et al. 2010).
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Preparation of PCIS
PCIS were prepared in ice-cold KHB by the Krumdieck
tissue slicer (Alabama Research and Development). The
slices with a wet weight of 3–4 mg had an estimated
thickness of 300–400 lm (De Graaf et al. 2010). Slices
were stored in ice-cold KHB until the start of the experi-
ments (De Graaf et al. 2010).
Incubation of intestinal slices
Slices were incubated in 12-well plates for human PCIS
(hPCIS) and rat PCIS (rPCIS) or in 24-well plates for
mouse PCIS (mPCIS). hPCIS and rPCIS were incubated
individually in 1.3 mL and mPCIS in 0.5 mL of Williams
Medium E with L-glutamine (Invitrogen, Paisly, UK)
supplemented with 25 mM glucose, 50 lg/mL gentamycin
(Invitrogen), and 2.5 lg/mL amphotericin-B (Invitrogen).
During incubation (at 37°C and 80% O2/5% CO2) in an
incubator (MCO-18M, Sanyo), the plates were horizon-
tally shaken at 90 rpm (amplitude 2 cm). rPCIS were
incubated up to 24 h, mPCIS and hPCIS were incubated
up to 72 h, with and without human TGF-b1 (Roche
Diagnostics, Mannheim, Germany) in the concentration
range from 1 to 10 ng/mL. All incubations were per-
formed manifold (using 3–6 slices incubated individually
in separate wells) and were repeated with intestine from 3
to 16 different humans, rats, or mice.
Viability and morphology
The viability was assessed by measuring the adenosine tri-
phosphate (ATP) content of the PCIS, as was previously
described (De Graaf et al. 2010). Briefly, after incubation,
slices were transferred to 1 mL sonication solution
(containing 70% ethanol and 2 mM EDTA), snap-frozen
in liquid nitrogen and stored at 80°C. To determine the
viability, ATP levels were measured in the supernatant of
samples sonicated for 45 sec and centrifuged for 2 min at
4°C at 16.000 9 g, using the ATP bioluminescence kit
(Roche Diagnostics, Mannheim, Germany). ATP values
(pmol) were normalized to the total protein content (lg)
of the PCIS estimated by Lowry method (BIO-rad RC
DC Protein Assay, Bio Rad, Veenendaal, The Nether-
lands). Values displayed are relative values compared to
the related controls.
To assess the morphology, incubated slices were fixed
in 4% formalin and embedded in paraffin. Sections of
4 lm were cut and stained with hematoxylin and eosin
(HE) (De Graaf et al. 2010). HE sections were scored
according to a modified Park score, describing the
sequence of development of tissue injury in the intestine
after ischemia and reperfusion (Park et al. 1990; Roskott
et al. 2010). The integrity of seven segments of the PCIS
was scored on a scale from 0 to 3. Viability of the epithe-
lium, stroma, crypts, and muscle layer were scored sepa-
rately rating 0 if there was no necrosis, and 3 if massive
necrosis was present. The other parts of the intestinal slice
were rated as follows: Shape of the epithelium: 0 = cubic
epithelium, 3 = more than 2/3 of the cells are flat, flatten-
ing of the villi: 0 = normal, 3 = more than 2/3 of the villi
are flattened, and the amount of edema: 0 = no edema,
3 = severe edema. A maximum score of 21 indicates
severe damage. In human samples, the morphological
score of muscularis mucosae was determined in the
“muscle layer” section. B.T.P., W.T.v.H. and J.N. per-
formed the blind scoring; the mean of three total scores
was calculated.
Gene expression
After incubation, slices were snap-frozen in liquid nitro-
gen and stored at 80°C until RNA isolation. First, total
RNA of three to six pooled snap-frozen slices was isolated
using Qiagen RNAeasy mini kit (Qiagen, Venlo, The
Netherlands). The amount of isolated RNA was measured
with the BioTek Synergy HT (BioTek Instruments, Ver-
mont). Afterward, reverse transcriptase was performed
with 1 lg RNA using Reverse Transcription System (Pro-
mega, Leiden, The Netherlands). The reverse transcript
polymerase chain reaction (PCR) reaction was performed
in the Eppendorf mastercycler with the following gradi-
ent: 25°C for 10 min, 45°C for 60 min, and 95°C for
5 min.
The expression of the fibrosis genes, namely COL1A1,
aSMA, HSP47, CTGF, FN2, TGF-b1, PAI-1, and SYN
were determined by either the Taqman or SYBRgreen
method. In hPCIS, ELA gene expression was also mea-
sured by SYBRgreen method. With the Taqman method,
the primers (50 lM) and probes (5 lM) listed in Table 2
were used with the qPCR mastermix plus (Eurogentec,
Table 1. Characteristics of human PCIS from nine Human donors.
Human ID Gender Age
ATP (0 h)
pmol/lg protein
IH1 F 73 4.70
IH2 F 80 1.60
IH3 M 68 1.70
IH4 F 66 7.90
IH5 M 33 2.30
IH6 F 66 4.18
IH7 M 53 5.36
IH8 F 71 3.10
IH9 M 53 3.71
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Maastricht, The Netherlands). The real-time PCR reaction
was performed in a 7900HT Real Time PCR (Applied
Biosystems, Bleiswijk, The Netherlands) with 40 cycles of
10 min at 95°C, 15 sec at 95°C and 1 min at 60°C. With
the SYBRgreen method, appropriate primers (50 lM),
listed in Table 2, were used with SYBRgreen mastermix
(GC Biotech, Alphen aan de Rijn, The Netherlands). The
real-time PCR reaction was performed with 45 cycles of
10 min 95°C, 15 sec at 95°C, and 25 sec at 60°C follow-
ing with a dissociation stage. Ct values were corrected for
the Ct values of the housekeeping gene GAPDH (ΔCt)
and compared with the control (ΔΔCt). Results are calcu-
lated as fold induction of the gene (2ΔΔCt).
Statistics
A minimum of three different intestines was used for
each experiment, using 3–6 slices from each intestine. The
results are expressed as mean  standard error of the
mean (SEM). Differences were determined using a paired,
one-tailed Student’s t-test and ANOVA multiple compari-
sons with Fisher’s least significant difference test. A
P-value <0.05 was considered significant. Statistical differ-
ences in ATP were determined using the values relative to
the control values in the same experiment. Real-time PCR
results were compared using the mean ΔΔCt values. Cor-
relation between ATP content and mean Park score was
determined using Spearman’s correlation coefficient.
Results
Viability of PCIS
The ATP content and the morphology of PCIS were used
to evaluate the viability of the slices during culturing.
Directly after slicing, the ATP content of the PCIS from
human (h), rat (r) and mouse (m) was 3.49  1.56,
4.34  1.69, 3.82  1.95 pmol/lg protein, respectively.
Table 2. Primers and probes of fibrosis markers.












Gapdh GAACATCATCCCTGCATCCA CCAGTGAGCTTCCCGTTCA CTTGCCCACAGCCTTGGCAGC
Col1a1 CCCACCGGCCCTACTG GACCAGCTTCACCCTTAGCA CCTCCTGGCTTCCCTG
aSma AGCTCTGGTGTGTGACAATGG GGAGCATCATCACCAGCAAAG CCGCCTTACAGAGCC







GAPDH ACCAGGGCTGCTTTTAACTCT GGTGCCATGGAATTTGCC TGCCATCAATGACCCCTTCA
COL1A1 CAATCACCTGCGTACAGAACGCC CGGCAGGGCTCGGGTTTC CAGGTACCATGACCGAGACGTG
aSMA AGGGGGTGATGGTGGGAA ATGATGCCATGTTCTATCGG GGGTGACGAAGCACAGAGCA
HSP47 GCCCACCGTGGTGCCGCA GCCAGGGCCGCCTCCAGGAG CTCCCTCCTGCTTCTCAGCG
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No significant difference in the ATP content of PCIS
from different species was found. When compared with
directly after slicing, the ATP content of hPCIS decreased
about 30% and 50%, after 48 and 72 h of incubation,
respectively (Fig. 1A). However, in rPCIS, already after
4 h of incubation the ATP content significantly decreased
and after 24 h the ATP content was reduced by 75%
compared to freshly prepared PCIS (Fig. 1B). In mPCIS,
the ATP content was not significantly different after 48 h
of incubation, yet, after 72 h of culturing, ATP levels were
significantly decreased to 36% as compared to freshly pre-
pared PCIS (Fig. 1C).
To evaluate the morphological integrity of PCIS after
incubation, the modified Park score was used. An
increased Park score indicated a decrease in viability.
Mean Park scores of hPCIS increased significantly during
48 h of culture when compared with hPCIS directly after
slicing (Fig. 2A). Furthermore, the mean Park score of
rPCIS and mPCIS also increased significantly during
incubation (Fig. 2B and C). Very low Park score of non-
incubated slices showed that PCIS were not damaged by
handling and slicing (Fig. 2). A significant correlation
between ATP content and mean Park scores was found in
hPCIS (Spearman r = 0.76, P < 0.0001), rPCIS (Spear-
man r = 0.73, P ≤ 0.0002) and mPCIS (Spearman
r = 0.82, P = 0.0033) (Fig. 2D–F).
During culturing of human, rat, and mouse intestinal
slices the same sequence of morphological changes and
damage was found (Fig. 3). First, epithelial and stromal
cells were damaged, with clear signs of necrosis in these
cells. In association, flattening of the villi and of epithelial
cells (i.e., losing their cubic shape), and development of
edema was found (Fig. 3B). Subsequently, necrosis was
evident in cells of the crypts and the muscle layer. By
incubating hPCIS up to 72 h, massive necrosis was appar-
ent in both epithelial and stromal cells (Fig. 3C). In asso-
ciation with necrosis, destruction of the normal tissue
architecture was found as shown in Figure 3C.
PCIS of all species were incubated with TGF-b1, to
confirm that PCIS can be used to study the TGF-b1
signaling pathway. hPCIS viability decreased slightly, but
not significantly, after 24 h of incubation with 10 ng/mL
TGF-b1. Meanwhile, when hPCIS were incubated for
48 h, TGF-b1 did not affect the hPCIS ATP content
(Fig. 4A). Moreover, ATP content of rPCIS did not
decreased after 24 h of incubation in the presence of up
to 5 ng/mL TGF-b1 (Fig. 4B). In contrast, 10 ng/mL of
TGF-b1 decreased the viability of rPCIS considerably
(data not shown). Meanwhile, in mPCIS, up to 48 h in
culture, no effect on the viability due to TGF-b1 was
observed (Fig. 4C).
Gene expression of fibrosis markers
To determine if the early-onset of fibrosis is induced in
PCIS, gene expression of various fibrosis markers was
investigated. After 24 h of incubation, the gene expression
of an early marker of fibrosis, HSP47, was elevated in
hPCIS when compared with hPCIS directly after slicing.
HSP47 steadily increased up to 72 h. Furthermore, when
compared with hPCIS after preparation, SYN gene expres-
sion significantly increased in hPCIS after 48 h and was
even higher after 72 h of incubation. Conversely, ELA
expression was decreased after 48 hr incubation (Fig. 7E)




Figure 1. Long-term incubation of hPCIS, rPCIS, and mPCIS. The
viability of PCIS as measured by ATP content (relative value
compare to 0 h) after incubation of (A) hPCIS up to 72 h, (B) rPCIS
up to 24 h, and (C) mPCIS up to 72 h. (*P < 0.05, **P < 0.01 vs.
0 h. n = 9–15, data are expressed as mean  SEM).
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up to 72 h compared to freshly prepared PCIS (Fig. 5A).
Furthermore, COL1A1, CTGF, and FN2 expression was
not affected during incubation of hPCIS (Fig. 5A).
After 24 h of incubation of rPCIS, the gene expression
of Hsp47 and Fn2 was significantly increased compared to
PCIS directly after slicing. Similar to hPCIS, aSma was
downregulated, whereas Col1a1, Ctgf, and Syn expression
was unaffected after 24 h of culture (Fig. 5B).
As was found in rPCIS the gene expression of Hsp47
and Fn2 was significantly increased in mPCIS after 24 h,
which increased even further up to 48 and 72 h of incuba-
tion. Ctgf expression was only increased after 72 h of incu-
bation in mPCIS. In contrast to the gene expression of
aSma and Col1a1, which was significantly downregulated
up to 72 h in mPCIS (Fig. 5C). Syn expression remained
unchanged during incubation in both rPCIS and mPCIS.
Addition of TGF-b1
To study if the main fibrogenic factor TGF-b1 was able
to induce fibrogenesis in these models, PCIS were incu-
bated with TGF-b1. The gene expression of none of the
investigated fibrosis markers was affected in hPCIS when
incubated for 48 h with up to 10 ng/mL TGF-b1
(Figs. 6A and 7E). However, in rPCIS, when incubated
for 24 h with 1 ng/mL TGF-b1, Ctgf, and Fn2 were sig-
nificantly upregulated compared to control and remain






Figure 2. Park score of hPCIS, rPCIS, and mPCIS after long-term incubation. Mean Park scores of (A) hPCIS, (B) rPCIS, and (C) mPCIS after
different incubation intervals. (by BTP, JN, and WTvH, *P < 0.05, n = 5–8, data are expressed as mean +/- SEM). (D) Spearman correlation
between ATP content and mean Park score in hPCIS (r = 0.76, P < 0.0001), (E) rPCIS (r = 0.73, P ≤ 0.0001) and (F) mPCIS (r = 0.81,
P = 0.0015).
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aSma and Col1a1 expression were significantly increased
compared to the 24 h control only, when incubated with
5 ng/mL TGF-b1. Interestingly, Hsp47 expression in
rPCIS tended to decrease with 1 ng/mL TGF-b1 and was
significantly downregulated when adding 5 ng/mL TGF-
b1 during culture (Fig. 6B). In mPCIS after 48 h of incu-
bation in the presence of 5 ng/mL TGF-b1 the gene
expression of Col1a1, Fn2, Hsp47, and Ctgf was signifi-
cantly upregulated compared to the 48 h control
(Fig. 6C). However, Syn expression was not affected in
both rPCIS and mPCIS in the presence of TGF-b1.
Both TGF-b1 and PAI-1, the specific downstream mar-
ker of TGF-b1 signaling (Kuang et al. 2007), gene expres-
sion were investigated. Only in rPCIS the Tgf-b1 was
significantly increased (Fig. 7B). However, the gene
expression of PAI-1 was increased dramatically in all spe-
cies suggesting activation of the TGF-b1 pathway
(Fig. 7A–C). When slices were incubated in the presence
of TGF-b1, the gene expression PAI-1 was not further
increased, except for rPCIS (Fig. 7D).
Discussion
Intestinal fibrosis is a complicated condition, caused by
extensive chronic inflammation or injury of the bowel.
Although there are some animal models for IF, most of
them are limited in their relevance to human disease and
have some definite disadvantages, such as animal discom-
fort and long time needed to establish the fibrosis state
(Rieder et al. 2012). Until now, there are no antifibrotic
drugs available and relevant models are needed. As




Figure 4. Long-term incubation of hPCIS, rPCIS, and mPCIS with
TGF-b1. The viability of PCIS as measured by ATP content (relative
value compare to control) after incubation of: (A) hPCIS up to 48 h
with 5 ng/mL and 10 ng/mL TGF-b1, (B) rPCIS up to 24 h with
1 ng/mL and 5 ng/mL TGF-b1 and (C) mPCIS up to 48 h with 5 ng/
mL TGF-b1. (*P < 0.05, **P < 0.01 vs. control n = 3–6, data are




Figure 3. Morphological integrity of hPCIS after long-term
incubation. HE staining of representative healthy hPCIS after (A)
0 h, (B) 48 h, and (C) 72 h incubation (magnification: 49).
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good model to study the early-onset of organ fibrosis
(Westra et al. 2013), and can also considerably reduce the
number of animals used in intestinal fibrosis research.
The aim of this study was to develop a method for study-
ing the early-onset of IF by using PCIS from various spe-
cies, namely human, rat, and mouse.
Viability by ATP content of PCIS
Precision-cut intestinal slices have been used previously
to study drug metabolism and toxicity in the intestinal
tract. In these studies, hPCIS were used to investigate the
regulation, expression and capacity of metabolic enzymes,
transporters and receptors indicating that PCIS can
mimic the intestine in vivo (Van De Kerkhof et al.
2006; Van de Kerkhof et al. 2008; Khan A.A. et al. 2009;
Khan et al. 2010). Previously, hPCIS were incubated for
a relatively short period of time (up to 24 h). To study
the onset of fibrosis, we incubated PCIS for a longer




Figure 6. Gene expression of fibrosis markers in hPCIS, rPCIS, and
mPCIS after long-term incubation with TGF-b1. The gene
expression of fibrosis markers COL1A1, HSP47, aSMA, CTGF, FN2,
and SYN after incubation of (A) hPCIS for 48 h with 5 ng/mL and
10 ng/mL TGF-b1, (B) rPCIS for 24 h with 1 ng/mL and 5 ng/mL
TGF-b1, and (C) mPCIS for 48 h with 5 ng/mL TGF-b1. (*P < 0.05,





Figure 5. Gene expression of fibrosis markers in hPCIS, rPCIS, and
mPCIS after long-term incubation. The gene expression of fibrosis
markers COL1A1, HSP47, aSMA, CTGF, FN2, and SYN after
incubation of (A) hPCIS for 72 h, (B) rPCIS for 24 h, and (C) mPCIS
for 48 h. (*P < 0.05, **P < 0.01 vs. 0 h. n = 3–6, data are
expressed as mean  SEM).
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72 h). ATP is used in precision-cut tissue slices from
different organs as general marker of viability. To estab-
lish this in PCIS the morphology during incubation was
compared to the ATP content in the slices. Morphologi-
cal scoring (according to the modified Park score (Park
et al. 1990; Roskott et al. 2010)) of mPCIS, rPCIS, and
hPCIS showed that the ATP is related to the morpho-
logical integrity of the tissue. Therefore, ATP levels in
PCIS are used as a general marker for morphological
integrity in different species in this study. In addition,
the sequence of losing cell integrity in PCIS from differ-
ent species is similar, indicating that the same processes
take place in the PCIS from all studied species. Epithe-
lial and stromal cell damage was observed first, indicat-
ing that these cells are the most vulnerable to ischemia.
This is also shown in the original article describing the
Park score (Park et al. 1990). However, more specific
markers for the different cell types in the PCIS are nec-
essary to obtain information on the viability of these
cells in PCIS during culture.
The decline of ATP content found in our study was
also observed in other studies with rPCIS (Van de Kerk-
hof et al. 2007) and hPCIS (De Graaf et al. 2010). More-
over, PCIS from the different species behave differently
during culture. The ATP content in PCIS directly after




Figure 7. Gene expression of TGF-b1 and PAI-1 in hPCIS, rPCIS and mPCIS after long-term incubation with TGF-b1. The gene expression of
fibrosis markers TGF-b1 and PAI-1 after incubation of (A) hPCIS for 48 h, (B) rPCIS for 24 h, and (C) mPCIS for 48 h. (D) The gene expression
of PAI-1 in PCIS models after incubation (48 hr with hPCIS and mPCIS, 24 hr with rPCIS) with 5 ng/mL TGF-b1. (E) The gene expression of ELA
in hPCIS model after incubation for 48 hr with and without 5 ng/mL and 10 ng/mL TGF-b1 (*P < 0.05, **P < 0.01 vs. 0 h or control. n = 3–5,
data are expressed as mean  SEM.
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the species difference of the maximal incubation period
of the PCIS. In rPCIS after 24 h incubation ATP content
was less than 50% compared to directly after slicing, in
contrast to mPCIS and hPCIS, where this value was
reached only after 72 h. One of the factors may be the
production of reactive oxygen species (ROS). During slic-
ing and storage before the start of the incubation, the
PCIS are subjected to ischemia. Upon culturing, the PCIS
are reoxygenated. It is known from studies in biopsies
that in the rat intestine xanthine oxidase (XO) steeply
increases during ischemia, which is in contrast to the
human intestine (Bianciardi et al. 2004). Upon reoxygen-
ation, XO will lead to ROS and subsequently to cell and
tissue damage (Bianciardi et al. 2004). Furthermore, Tgf-
b1 gene expression was also increased in rPCIS, possibly
subsequently also TGF-b1 protein and this could lead to
the production of ROS (Rhyu et al. 2005; Yan et al.
2014). This might explain why rPCIS deteriorate faster in
culture than mPCIS and hPCIS. Future studies will be
performed to determine ROS production in PCIS of dif-
ferent species.
Gene expression of fibrosis markers
The aim of our study was to induce the early-onset of fi-
brogenesis, which could be triggered by the loss of cell
integrity over time. Therefore, we studied the gene
expression of different fibrosis markers, often linked to
the protein expression (Westra et al. 2014a,b). In addi-
tion, TGF-b1 was added to the PCIS to establish if one of
the main inducers of fibrogenesis is also effective in PCIS.
In hPCIS cultured up to 72 h, HSP47 gene expression
was elevated. Other studies have identified HSP47 as a
potential early marker of IF (Taguchi and Razzaque 2007;
Honzawa et al. 2010). It has been demonstrated that the
serum level of HSP47 is higher in CD patients, who are
prone for IF, compared to those with ulcerative colitis, an
intestinal disease that rarely leads to IF, and to control
patients (Taguchi et al. 2011). Moreover, Honzawa et al.
showed that HSP47 expression contributes to IF in CD
(Honzawa et al. 2014) and in the IL-10/ mouse model
of IF, HSP47 plays an essential role (Kitamura et al. 2011;
Rieder et al. 2012). Therefore, HSP47 is a biomarker for
IF and furthermore used ex vivo in hPCIS to study the
efficacy of antifibrotic drugs(Taguchi et al. 2011).
SYN, a marker of stellate cells (Cassiman et al. 1999),
was also upregulated in hPCIS. As was reported before by
Rieder et al. (Rieder and Fiocchi 2008) stellate cells are
present in the intestine and may contribute to the fibrotic
process. As was shown before with hepatic stellate cells
(HSCs), if the liver is injured, HSCs change their pheno-
type to an activated state, start to express among others
aSMA, and to synthesize proinflammatory cytokines and
ECM proteins (Li and Friedman 1999). Intestinal stellate
cells seem to display the same basic morphological, phe-
notypic, and functional characteristics as the hepatic stel-
late cell and recently have been isolated and cultured
from mesenteric fibrotic tissue from a patient with a
fibrotic carcinoid tumor (Kidd et al. 2007; Fiocchi and
Lund 2011). Therefore, the increase in stellate cell number
and HSP47 induction up to 72 h in hPCIS during cultur-
ing indicates that slices can be used as a tool to study the
early stage of fibrosis.
The decrease in aSMA expression up to 72 h in hPCIS
might be explained by a loss of fibroblasts, which was also
found in other organ slices (Westra et al. 2013). In
hPCIS, none of the other fibrosis markers (COL1A1, FN2,
and ELA) were increased during culturing, even with the
addition of increasing concentrations of TGF-b1. This
may indicate that the TGF-b pathway cannot be induced,
or is already activated due to the operation and procure-
ment of the tissue. Moreover, it should be noted that in
the intestine, the resident macrophages are mainly in the
muscularis (Smith et al. 2011), which was removed from
the human intestinal tissue before hPCIS were prepared.
Although the mechanism of IF in human is still
unknown, the spontaneous early fibrosis may require
macrophages to develop. Future studies with specific
inhibitors of the TGF-b pathway will elucidate if the
pathway is already activated. Furthermore, maybe an
additional trigger such as PDGF or the presence of the
inflammatory cytokine TNFa is necessary to induce fibro-
sis in hPCIS, which has been reported in liver fibrosis
and idiopathic pulmonary fibrosis (Kropski et al. 2012;
Basaranoglu et al. 2013). In future experiments with PCIS
it will be elucidate if a second hit is necessary. In human
liver slices, not only TGF-b1 but both potent fibrogenic
factors PDGF and TGF-b1 are necessary to induce gene
expression of fibrosis markers (Westra et al. 2011).
Research is currently ongoing to further induce the gene
expression of fibrosis markers in hPCIS.
We have investigated the gene expression of ELA in the
hPCIS. Although it has been reported that ELA was acti-
vated by TGF-b1 in lung fibroblasts (Kuang et al. 2007),
there is no reports of the involvement of elastin in fibro-
sis in other organs. In hPCIS, ELA was not induced dur-
ing incubation with or without TGF-b1. This may
indicate that the activation of elastin is lung specific.
In rPCIS, both Hsp47 and Fn2 were increased after
24 h of culture. These results imply that the early-onset
of fibrogenesis is indeed induced in rPCIS during culture
up to 24 h. Addition of TGF-b1 further increased Fn2
expression, but not Hsp47 that was downregulated by
TGF-b1. This may be explained by the fact that for the
early fibrosis marker Hsp47, the maximum gene expres-
sion was reached earlier by adding TGF-b1 during rPCIS
2015 | Vol. 3 | Iss. 4 | e12323
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incubation than in the control incubation of rPCIS. This
is in accordance with the results of Col1a1, the marker of
fibrosis, that was only elevated in rPCIS by TGF-b1, as
was also seen in other organ slices (Westra et al. 2011).
Similarly, Ctgf expression was only elevated in rPCIS after
the addition of TGF-b1, this is in line with the function
of Ctgf in the TGF-b pathway (Brigstock 2010). As was
assessed in hPCIS, aSma expression was also decreased in
rPCIS, indicating again that fibroblasts may be lost during
culture. However, aSma expression was increased in
rPCIS by TGF-b1. This may suggest that (myo)fibroblasts
are activated by TGF-b1 in rPCIS.
In accordance with the results in rPCIS, prolonged cul-
ture of mPCIS induced Hsp47 and Fn2 expression, but
aSma was decreased during culture up to 72 h. However,
unlike rPCIS and hPCIS, where Col1a1 was unchanged
during culture, in mPCIS the gene expression of Col1a1
was significantly decreased. In an ex vivo model of liver
fibrosis (Westra et al. 2014b), Col1a1 was also downregu-
lated after 24 h incubation, but increased after 48 h incu-
bation due to activation of the wound repair system
(Vickers and Fisher 2005). In mPCIS, probably longer
incubation in the presence of profibrotic cytokines is
needed to initiate the wound healing process and fibrosis.
Interestingly, only in mPCIS, Ctgf gene expression was up-
regulated after 72 h incubation, this is an indication that
the TGF-b pathway was activated after long-term incuba-
tion. Furthermore, addition of TGF-b1 to mPCIS-induced
gene expression of Col1a1, Fn2, Ctgf, and even Hsp47 that
was downregulated in rPCIS. aSma expression was not
affected by TGF-b1 in mPCIS. In contrast to hPCIS, Syn
was not induced in rPCIS and mPCIS, not even in the
presence of TGF-b1. This suggests differences between spe-
cies in the proliferation of intestinal stellate cells.
All these results imply that in rPCIS and mPCIS there
was a spontaneous induction of early fibrogenesis, which
can be measured by gene expression of Hsp47 and Fn2.
Our result of the early-onset of fibrosis in PCIS are in
line with the results in a liver fibrosis model using preci-
sion-cut liver slices, which we already successfully used in
studying antifibrotic compounds (Westra et al. 2014b).
Future studies with specific signaling pathway inhibitors
will be performed to elucidate why during culturing of
PCIS spontaneous induction of these markers occurs.
TGF-b1 was able to even further stimulate the onset of
fibrosis in rat and mouse, indicating the importance of
TGF-b1 as profibrotic stimulus in rodents. Upcoming
experiments have to clarify if the TGF-b1 pathway is
involved in the spontaneous activation of early fibrogene-
sis in PCIS. Moreover, we found clear species differences
in the early-onset of fibrosis, therefore, we are currently
performing studies, among others by staining different
intestinal cell types, to elucidate these difference.
Conclusion
We successfully developed a relevant ex vivo intestinal
model in both rodent and man to study the early-onset
of intestinal fibrosis. In rat and mouse PCIS, TGF-b1 was
able to even further increase the gene expression of fibro-
sis markers. The gene expression of HSP47 in human and
rodent PCIS, and in rodent PCIS also Fn2, can be used as
early markers of fibrosis. These results open the opportu-
nity to test the efficacy of antifibrotic drugs in both
human and rodents in an ex vivo physiological model.
The model also provides the opportunity to study the
fibrogenesis in different regions of the intestine. Further-
more, the mechanism of fibrosis in an ex vivo model of
early fibrogenesis in different species can be determined.
The research is currently expanding to the diseased
human (fibrotic) intestine.
Conflict of Interest
None of the authors has anything to declare.
References
Basaranoglu, M., G. Basaranoglu, and H. Sent€urk. 2013. From
fatty liver to fibrosis: a tale of “second hit”. World
J. Gastroenterol. 19:1158–1165.
Bianciardi, P., R. Scorza, G. Ghilardi, and M. Samaja. 2004.
Xanthine oxido-reductase activity in ischemic human and
rat intestine. Free Radic. Res. 38:919–925.
Brigstock, D. R. 2010. Connective tissue growth factor (CCN2,
CTGF) and organ fibrosis: lessons from transgenic animals.
J. Cell Commun. Signal. 4:1–4.
Cassiman, D., J. van Pelt, R. De Vos, F. Van Lommel,
V. Desmet, S. H. Yap, et al. 1999. Synaptophysin: A novel
marker for human and rat hepatic stellate cells. Am.
J. Pathol. 155:1831–1839.
De Graaf, I.A., P. Olinga, de Jager M. H., M. T. Merema, de
Kanter R., devan Kerkhof E. G., et al. 2010. Preparation and
incubation of precision-cut liver and intestinal slices for
application in drug metabolism and toxicity studies. Nat.
Protoc. 5:1540–1551.
Dendooven, A., K. G. Gerritsen, T. Q. Nguyen, R. J. Kok, and
R. Goldschmeding. 2011. Connective tissue growth factor
(CTGF/CCN2) ELISA: a novel tool for monitoring fibrosis.
Biomarkers 16:289–301.
Fiocchi, C., and P. K. Lund. 2011. Themes in fibrosis and
gastrointestinal inflammation. Am. J. Physiol. Gastrointest.
Liver Physiol. 300:G677–G683.
Froehlich, F., P. Juillerat, C. Mottet, C. Felley, J.-P. Vader,
B. Burnand, et al. 2005. Obstructive fibrostenotic Crohn’s
disease. Digestion 71:29–30.
de Graaf, I. A., G. M. Groothuis, and P. Olinga. 2007.
Precision-cut tissue slices as a tool to predict metabolism
ª 2015 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
the American Physiological Society and The Physiological Society.
2015 | Vol. 3 | Iss. 4 | e12323
Page 11
B. T. Pham et al. Precision-Cut Slice as a Model for Intestinal Fibrosis
of novel drugs. Expert Opin. Drug Metab. Toxicol. 3:879–
898.
Honzawa, Y., H. Nakase, Y. Takeda, K. Nagata, and T. Chiba.
2010. Heat shock protein 47 can be a new target molecule
for intestinal fibrosis related to inflammatory bowel disease.
Inflamm. Bowel Dis. 16:2004–2006.
Honzawa, Y., H. Nakase, M. Shiokawa, T. Yoshino,
H. Imaeda, M. Matsuura, et al. 2014. Involvement of
interleukin-17A-induced expression of heat shock protein
47 in intestinal fibrosis in Crohn’s disease. Gut 63:1902–
1912.
Khan A.A., E. C. Y. Chow, vanLoenen-Weemaes A. M.,
R. J. Porte, K. S. Pang, and G. M. M. Groothuis. 2009.
Comparison of effects of VDR versus PXR, FXR and GR
ligands on the regulation of CYP3A isozymes in rat and
human intestine and liver. Eur. J. Pharm. Sci. 37:115–125.
Khan, A. A., B. S. Dragt, R. J. Porte, and G. M. M. Groothuis.
2010. Regulation of VDR expression in rat and human
intestine and liver–consequences for CYP3A expression.
Toxicol. In Vitro 24:822–829.
Kidd, M., I. M. Modlin, M. D. Shapiro, R. L. Camp,
S. M. Mane, W. Usinger, et al. 2007. CTGF, intestinal
stellate cells and carcinoid fibrogenesis. World
J. Gastroenterol. 13:5208–5216.
Kitamura, H., S. Yamamoto, H. Nakase, M. Matsuura,
Y. Honzawa, K. Matsumura, et al. 2011. Role of heat shock
protein 47 in intestinal fibrosis of experimental colitis.
Biochem. Biophys. Res. Commun. 404:599–604.
Kropski, J.A., W. E. Lawson, and T. S. Blackwell. 2012. Right
place, right time: the evolving role of herpesvirus infection
as a “second hit” in idiopathic pulmonary fibrosis. AJP
Lung Cell. Mol. Physiol. 302:L441–L444.
Kuang, P-P., X-H. Zhang, C. B. Rich, J. A. Foster,
M. Subramanian, and R. H. Goldstein. 2007. Activation of
elastin transcription by transforming growth factor-beta in
human lung fibroblasts. Am. J. Physiol. Lung Cell. Mol.
Physiol. 292:L944–L952.
Kutz, S. M., J. Hordines, P. J. McKeown-Longo, and
P. J. Higgins. 2001. TGF-beta1-induced PAI-1 gene
expression requires MEK activity and cell-to-substrate
adhesion. J. Cell Sci. 114:3905–3914.
Latella, G., R. Sferra, S. Speca, A. Vetuschi, and E. Gaudio.
2013. Can we prevent, reduce or reverse intestinal fibrosis in
IBD? Eur. Rev. Med. Pharmacol. Sci. 17:1283–1304.
Li, D., and S. L. Friedman. 1999. Liver fibrogenesis and the
role of hepatic stellate cells: new insights and prospects for
therapy. J. Gastroenterol. Hepatol. 14:618–633.
Louis, E., A. Collard, A. F. Oger, E. Degroote, F. A. Aboul
Nasr El Yafi, and J. Belaiche. 2001. Behaviour of Crohn’s
disease according to the Vienna classification: changing
pattern over the course of the disease. Gut 49:777–782.
Lund, P. K., and R. J. Rigby. 2008. What are the mechanisms
of fibrosis in IBD? Inflamm. Bowel Dis. 14(Suppl 2):S127–
S128.
Niu, X., deGraaf I. A., and G. M. M. Groothuis. 2013. Evaluation
of the intestinal toxicity and transport of xenobiotics utilizing
precision-cut slices. Xenobiotica 43:73–83.
Park, P. O., U. Haglund, G. B. Bulkley, and K. F€alt. 1990. The
sequence of development of intestinal tissue injury after
strangulation ischemia and reperfusion. Surgery 107:574–
580.
Possidente, M., S. Dragoni, G. Franco, M. Gori, E. Bertelli,
E. Teodori, et al. 2011. Rat intestinal precision-cut slices
as an in vitro model to study xenobiotic
interaction with transporters. Eur. J. Pharm. Biopharm.
79:343–348.
Rhyu, D. Y., Y. Yang, H. Ha, G. T. Lee, J. S. Song, S. Uh,
et al. 2005. Role of reactive oxygen species in TGF-beta1-
induced mitogen-activated protein kinase activation and
epithelial-mesenchymal transition in renal tubular epithelial
cells. J. Am. Soc. Nephrol. 16:667–675.
Rieder, F., and C. Fiocchi. 2008. Intestinal fibrosis in
inflammatory bowel disease – current knowledge and future
perspectives. J. Crohns. Colitis 2:279–290.
Rieder, F., and C. Fiocchi. 2009. Intestinal fibrosis in IBD–a
dynamic, multifactorial process. Nat. Rev. Gastroenterol.
Hepatol. 6:228–235.
Rieder, F., J. Brenmoehl, S. Leeb, J. Sch€olmerich, and
G. Rogler. 2007. Wound healing and fibrosis in intestinal
disease. Gut 56:130–139.
Rieder, F., S. Kessler, M. Sans, and C. Fiocchi. 2012. Animal
models of intestinal fibrosis: new tools for the understanding
of pathogenesis and therapy of human disease. Am. J.
Physiol. Gastrointest. Liver Physiol. 303:G786–G801.
Roskott, A. M., V. B. Nieuwenhuijs, H. G. D. Leuvenink,
G. Dijkstra, P. Ottens, deJager M. H., et al. 2010. Reduced
ischemia-reoxygenation injury in rat intestine after luminal
preservation with a tailored solution. Transplantation
90:622–629.
Silverstein, M. D., E. V. Loftus, W. J. Sandborn, W. J.
Tremaine, B. G. Feagan, P. J. Nietert, et al. 1999. Clinical
course and costs of care for Crohn’s disease: Markov model
analysis of a population-based cohort. Gastroenterology
117:49–57.
Smith, P. D., L. E. Smythies, R. Shen, T. Greenwell-Wild,
M. Gliozzi, and S. M. Wahl. 2011. Intestinal macrophages
and response to microbial encroachment. Mucosal
Immunol. 4:31–42.
Taguchi, T., and M. S. Razzaque. 2007. The collagen-specific
molecular chaperone HSP47: is there a role in fibrosis?
Trends Mol. Med. 13:45–53.
Taguchi, T., A. Nazneen, A. A. Al-Shihri, K. A. Turkistani, and
M. S. Razzaque. 2011. Heat shock protein 47: a novel
biomarker of phenotypically altered collagen-producing
cells. Acta Histochem. Cytochem. 44:35–41.
To, W. S., and K. S. Midwood. 2011. Plasma and cellular
fibronectin: distinct and independent functions during tissue
repair. Fibrogen. Tissue Rep. 4:21.
2015 | Vol. 3 | Iss. 4 | e12323
Page 12
ª 2015 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
the American Physiological Society and The Physiological Society.
Precision-Cut Slice as a Model for Intestinal Fibrosis B. T. Pham et al.
Van de Bovenkamp, M., G. M. M. Groothuis, D. K. F. Meijer,
M. J. H. Slooff, and P. Olinga. 2006. Human liver slices as
an in vitro model to study toxicity-induced hepatic stellate
cell activation in a multicellular milieu. Chem. Biol.
Interact. 162:62–69.
Van De Kerkhof, E.G., L. B. Ungella, A. K. Sj€oberg, M. H. De
Jager, C. Hilgendorf, I. A. M. De Graaf, et al. 2006.
Innovative methods to study human intestinal drug
metabolism in vitro: precision-cut slices compared with
Ussing chamber preparations. Drug Metab. Dispos. 34:1893–
1902.
Van de Kerkhof, E. G., I. A. M. de Graaf, M. H. de Jager, and
G. M. M. Groothuis. 2007. Induction of phase I and II drug
metabolism in rat small intestine and colon in vitro. Drug
Metab. Dispos. 35:898–907.
Van de Kerkhof, E. G., I. A. M. de Graaf, A.-L. B. Ungell, and
G. M. M. Groothuis. 2008. Induction of metabolism and
transport in human intestine: validation of precision-cut
slices as a tool to study induction of drug metabolism in
human intestine in vitro. Drug Metab. Dispos. 36:604–613.
Vickers, A. E. M., and R. L. Fisher. 2005. Precision-cut organ
slices to investigate target organ injury. Expert Opin. Drug
Metab. Toxicol. 1:687–699.
Westra, I. M., D. Oosterhuis, G. M. Groothuis, and P. Olinga.
2011. Induction of fibrotic markers in an in vitro model of
liver fibrosis. Hepatology 54:754A–755A.
Westra, I. M., B. T. Pham, G. M. M. Groothuis, and
P. Olinga. 2013. Evaluation of fibrosis in precision-cut tissue
slices. Xenobiotica 43:98–112.
Westra, I. M., D. Oosterhuis, G. M. M. Groothuis, and
P. Olinga. 2014a. The effect of antifibrotic drugs in rat
precision-cut fibrotic liver slices. PLoS ONE 9:e95462.
Westra, I. M., D. Oosterhuis, G. M. M. Groothuis, and
P. Olinga. 2014b. Precision-cut liver slices as a model for
the early onset of liver fibrosis to test antifibrotic drugs.
Toxicol. Appl. Pharmacol. 274:328–338.
Yan, F., Y. Wang, X. Wu, H. M. Peshavariya, G. J. Dusting,
M. Zhang, et al. 2014. Nox4 and redox signaling mediate
TGF-b-induced endothelial cell apoptosis and phenotypic
switch. Cell Death Dis. 5:e1010.
ª 2015 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
the American Physiological Society and The Physiological Society.
2015 | Vol. 3 | Iss. 4 | e12323
Page 13
B. T. Pham et al. Precision-Cut Slice as a Model for Intestinal Fibrosis
